SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹34 Cr | ₹27 Cr | ₹26 Cr | ₹1,587,742 Cr | ₹16 Cr |
What is the latest Profit Before Tax of SYNCOM FORMULATIONS (INDIA) ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹1,587,742 Cr |
| Mar2017 | ₹16 Cr |
How is Profit Before Tax of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 27.77 | |
| Mar2024 | ₹27 Cr | 1.52 | |
| Mar2023 | ₹26 Cr | -100.00 | |
| Mar2022 | ₹1,587,742 Cr | 9,861,041.23 | |
| Mar2017 | ₹16 Cr | - | |
Compare Profit Before Tax of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,360.2 Cr | 2.1% | -5.8% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.1% |
-5.8% |
-29.5% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses